Drugs for Alzheimer's disease: Where are we coming from? Where are we going?

Affiliations

• ¹ Institut Hospitalo Universitaire HealthAge, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, Toulouse 31000, France; Center for Epidemiology and Research in Population Health (CERPOP), University of Toulouse, INSERM UMR1295, UPS, Toulouse 31000, France. Electronic address: angioni.da@chu-toulouse.fr.
• ² Institut Hospitalo Universitaire HealthAge, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, Toulouse 31000, France; Center for Epidemiology and Research in Population Health (CERPOP), University of Toulouse, INSERM UMR1295, UPS, Toulouse 31000, France.
• ³ Center for Epidemiology and Research in Population Health (CERPOP), University of Toulouse, INSERM UMR1295, UPS, Toulouse 31000, France; Department of Epidemiology and Public Health, Toulouse University Hospital, Toulouse 31000, France.
• ⁴ Institut Hospitalo Universitaire HealthAge, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, Toulouse 31000, France.
• ⁵ Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230026, China.